Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rosie Barker
Financial Interests of Patient Organisations Contributing to Technology Assessment at England’s National Institute for Health and Care Excellence: Policy Review
British Medical Journal
Medicine
Related publications
Php295 - Review of Possible Causes of Variation in National Institute for Health and Care Excellence (Nice) Technology Appraisals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
National Institute for Health and Clinical Excellence
Journal of Neonatal Nursing
Pediatrics
Midwifery
Maternity
Utility Values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php272 - Quantitative Assessment of Technical Errors Found in Economic Models Submitted to the National Institute for Health and Care Excellence (Nice)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Different Values in Cost-Effectiveness Research: Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm80 - The Use of External Data to Better Inform Survival Extrapolations in Submissions to the National Institute for Health and Care Excellence (Nice)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines From the European Society of Cardiology and National Institute for Health and Care Excellence
European Cardiology Review
Cardiovascular Medicine
Cardiology
Urological Recommendations From the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: Suspected Cancer: Recognition and Referral
BJU International
Urology
A Critical Appraisal and Implications of the New National Institute for Health and Care Excellence Guideline on Dupilumab for Treating Moderate-To-Severe Atopic Eczema
British Journal of Dermatology
Dermatology
Medicine
